Novavax’s shares soared by 50% on Monday after the announcement of a new multibillion-dollar deal with French drugmaker Sanofi. This deal marks a significant turnaround for Novavax, which had been struggling with doubts about its financial viability. The stock had nearly doubled on Friday following the licensing agreement with Sanofi. CEO John Jacobs expressed confidence
Business
In a time when many eateries are facing a slump in sales and declining traffic due to a broader consumer slowdown, some restaurant chains like Chipotle Mexican Grill, Wingstop, and Sweetgreen are thriving, thanks to high-income consumers. While giants like McDonald’s, Starbucks, and Yum Brands have reported a weak start to 2024, the fast-casual segment
Moderna announced on Friday that the Food and Drug Administration has postponed the approval of its vaccine for respiratory syncytial virus (RSV) to the end of May. The delay was attributed to “administrative constraints” at the agency, which caught many investors by surprise as the decision was expected to be made earlier. Despite the setback,
The upcoming bout between Mike Tyson and Jake Paul has created massive hype and anticipation among boxing fans and sports enthusiasts. Scheduled to take place on July 20 at AT&T Stadium in Arlington, Texas, the fight is already seeing a surge in ticket prices and strong interest from bettors. This match, which will be streamed
The absence of a Marvel film to kick off the summer movie season in 2024 is a significant departure from recent years. For more than a decade, Marvel Cinematic Universe films have dominated the summer box office, consistently generating massive openings of over $100 million. However, this year, the mantle was picked up by Universal’s
Oddity Tech, the Israeli cosmetics platform utilizing artificial intelligence, has defied expectations with its first-quarter results. The company reported earnings per share of 61 cents adjusted, surpassing the anticipated 49 cents. Additionally, their revenue of $211.63 million exceeded the expected $205 million. This impressive performance resulted in a net income of $32.98 million, or 53
Former Starbucks CEO Howard Schultz has recently commented on the company’s disappointing quarterly report, expressing his belief that Starbucks can bounce back by enhancing its U.S. stores. Schultz, though no longer holding a formal role within the organization, pinpointed a crucial factor contributing to the decline. He emphasized the necessity for Starbucks to improve its
Amgen’s stock saw a significant increase of more than 12% after providing positive initial data on its new weight loss injection, MariTide. This announcement fueled concerns among investors regarding the potential new competition in the rapidly expanding weight loss drug market. As a result, the shares of the current major players in the obesity drug
Wayfair announced a decline in sales during its first quarter, reporting a reduction in losses following a 13% cut in its workforce earlier in the year. The online furniture retailer managed to surpass Wall Street’s expectations in terms of both revenue and losses, with active customer numbers growing by nearly 3% compared to the previous
Johnson & Johnson recently announced a $6.5 billion settlement to resolve the thousands of lawsuits in the U.S. claiming that their talc-based products caused ovarian cancer. This settlement, spanning over 25 years, aims to put an end to the financial and public relations troubles that J&J has faced due to these legal battles. The company